NCT07440004

Brief Summary

The purpose of this clinical trial is to see whether the Healthy Minds Program (HMP) is practical to use, well-received, and shows early signs of helping people who have recently experienced suicidal thoughts or behaviors. Participants will:

  • complete questionnaires
  • use HMP app for 4 weeks

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for phase_1

Timeline
0mo left

Started Apr 2026

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Apr 2026Aug 2026

First Submitted

Initial submission to the registry

February 23, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 27, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

April 10, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 11, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 11, 2026

Last Updated

July 21, 2026

Status Verified

July 1, 2026

Enrollment Period

4 months

First QC Date

February 23, 2026

Last Update Submit

July 17, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Columbia Suicide Severity Rating Scale (C-SSRS)

    The Columbia-Suicide Severity Rating Scale (C-SSRS) scores suicide risk based on 10 categories of suicidal ideation and behavior, with affirmative "Yes" answers indicating risk and determining the need for intervention. It assesses both severity (0-5, with 1 being least and 5 most severe) and behavior (6-10). A "Yes" to items 1-2 implies lower risk; 3 indicates moderate risk; and 4-6 indicate high risk.

    Baseline, Post-Intervention (4 weeks)

Secondary Outcomes (4)

  • Change in Five Facet Mindfulness Questionnaire (FFMQ)

    Baseline, Post-Intervention (4 weeks)

  • Change in Behavioral Approach System and Behavioral Inhibition System Scale (BIS/BAS)

    Baseline, Post-Intervention (4 weeks)

  • Change in Self-Compassion Scale - Short Form (SCS-SF)

    Baseline, Post-Intervention (4 weeks)

  • Change in PROMIS : Meaning and Purpose Subscale

    Baseline, Post-Intervention (4 weeks)

Study Arms (1)

Healthy Minds Program

EXPERIMENTAL
Device: Healthy Minds Program

Interventions

Participants will receive access to the 4-week HMP Foundations module. The HMP app is a meditation-based smartphone app designed to promote and protect psychological well-being through sustainable skills training. The program is grounded in constituents of psychological well-being identified in empirical literature. HMP provides core content, with instruction administered through a curriculum of guided practices. HMP is based on research on eudaimonic well-being (e.g., environmental mastery, purpose) and brain-based skills that underlie these qualities (e.g., regulation of attention, mental flexibility). The full HMP has guided audio practices that address 4 constituents of well-being: awareness, connection, insight, and purpose. At post-treatment, participants will be given access to additional HMP content to support their continued practice.

Also known as: HMP
Healthy Minds Program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 18 or older
  • past month history of active suicidal ideation
  • English speaking
  • primary owner of smartphone
  • has regular access to the internet
  • able to validate their identity with a valid form of legal ID (via driver's license, student ID, state-issued ID, etc.)
  • able to understand the nature of the study, provide informed consent, and complete study procedures

You may not qualify if:

  • unable to understand the study procedures
  • not fluent in English
  • being unable to verify their identity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Wisconsin - Madison

Madison, Wisconsin, 53703, United States

Location

Study Officials

  • Brooke Ammerman, PhD

    University of Wisconsin, Madison

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 23, 2026

First Posted

February 27, 2026

Study Start

April 10, 2026

Primary Completion (Estimated)

August 11, 2026

Study Completion (Estimated)

August 11, 2026

Last Updated

July 21, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will share

Locations